Topical pravibismane was found to be safe and well-tolerated for all doses tested in subjects with moderate to severely infected, chronic diabetic foot ulcers Pravibismane treatment demonstrated favorable trends towards greater reduction of ulcer size and lower incidence of ulcer-related…
Microbion’s Topical Pravibismane Phase 1b Moderate or Severe Diabetic Foot Ulcer Infection Study is Published in International Wound Journal
This post was originally published on this site